156 related articles for article (PubMed ID: 7717300)
1. An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy.
Mehra MR; Ventura HO; Smart FW; Collins TJ; Ramee SR; Stapleton DD
Am J Cardiol; 1995 Apr; 75(12):853-4. PubMed ID: 7717300
[No Abstract] [Full Text] [Related]
2. Impact of converting enzyme inhibitors and calcium entry blockers on cardiac allograft vasculopathy: from bench to bedside.
Mehra MR; Ventura HO; Smart FW; Stapleton DD
J Heart Lung Transplant; 1995; 14(6 Pt 2):S246-9. PubMed ID: 8719495
[No Abstract] [Full Text] [Related]
3. Prolonged rat heart allograft survival after treatment with angiotensin converting enzyme inhibitor or a calcium antagonist.
Mjörnstedt L; Lukes D; Arvidsson N; Herlitz H; Olausson M
Scand J Urol Nephrol; 1998 Sep; 32(5):341-4. PubMed ID: 9825397
[TBL] [Abstract][Full Text] [Related]
4. Calcium channel blockers and angiotensin-converting enzyme inhibitors in the prevention of graft vasculopathy.
Paul LC
J Heart Lung Transplant; 2000 May; 19(5):409-13. PubMed ID: 10808146
[No Abstract] [Full Text] [Related]
5. The effect of combined Angiotensin-converting enzyme inhibition and calcium antagonism on allograft coronary vasculopathy validated by intravascular ultrasound.
Erinc K; Yamani MH; Starling RC; Crowe T; Hobbs R; Bott-Silverman C; Rincon G; Young JB; Feng J; Cook DJ; Smedira N; Tuzcu EM
J Heart Lung Transplant; 2005 Aug; 24(8):1033-8. PubMed ID: 16102438
[TBL] [Abstract][Full Text] [Related]
6. [Calcium channel blockers and angiotensin converting enzyme inhibitors in the treatment of high blood pressure].
Koster M
Ned Tijdschr Geneeskd; 1986 Aug; 130(34):1509-13. PubMed ID: 3020442
[No Abstract] [Full Text] [Related]
7. ACE-inhibitors, calcium antagonists and low systemic vascular resistance following cardiopulmonary bypass. A case-control study.
Myles PS; Olenikov I; Bujor MA; Davis BB
Med J Aust; 1993 May; 158(10):675-7. PubMed ID: 8487686
[TBL] [Abstract][Full Text] [Related]
8. Allograft aortopathy: an in vivo study of donor aorta involvement in cardiac allograft vasculopathy.
Mehra MR; Ventura HO; Stapleton DD; Karsan AK; Smart FW; Ramee SR; Collins TJ
Am Heart J; 1997 Jun; 133(6):698-702. PubMed ID: 9200398
[TBL] [Abstract][Full Text] [Related]
9. New developments in the diagnosis and management of cardiac allograft vasculopathy.
Mehra MR; Ventura HO; Smart FW; Stapleton DD; Collins TJ; Ramee SR; Murgo JP; White CJ
Tex Heart Inst J; 1995; 22(2):138-44. PubMed ID: 7647597
[TBL] [Abstract][Full Text] [Related]
10. Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study.
Mehra MR; Ventura HO; Chambers R; Collins TJ; Ramee SR; Kates MA; Smart FW; Stapleton DD
J Am Coll Cardiol; 1995 Nov; 26(6):1537-44. PubMed ID: 7594082
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after heart transplantation. Results of a prospective, randomized multicenter trail.
Brozena SC; Johnson MR; Ventura H; Hobbs R; Miller L; Olivari MT; Clemson B; Bourge R; Quigg R; Mills RM; Naftel D
J Am Coll Cardiol; 1996 Jun; 27(7):1707-12. PubMed ID: 8636558
[TBL] [Abstract][Full Text] [Related]
12. Captopril and platelet-activating factor (PAF) antagonist prevent cardiac allograft vasculopathy in rats: role of endogenous PAF and PAF-like compounds.
Crawford SE; Huang L; Hsueh W; Takami H; Gonzalez-Crussi F; Backer CL; Mu Y; Liu H; Mavroudis C
J Heart Lung Transplant; 1999 May; 18(5):470-7. PubMed ID: 10363692
[TBL] [Abstract][Full Text] [Related]
13. Effect of quinapril on intimal hyperplasia after coronary stenting as assessed by intravascular ultrasound.
Kondo J; Sone T; Tsuboi H; Mukawa H; Kosokabe T; Tsuzuki M; Tomida T; Suzuki T; Kamiya H; Hayashi K; Matsui H; Okumura K
Am J Cardiol; 2001 Feb; 87(4):443-5, A6. PubMed ID: 11179530
[TBL] [Abstract][Full Text] [Related]
14. [Calcium antagonists vs ACE inhibitors in the treatment of essential arterial hypertension in the aged].
Cellamare G; Poppa E; Sgobba G; Bianco G
Minerva Cardioangiol; 1989 Mar; 37(3):111-8. PubMed ID: 2546102
[TBL] [Abstract][Full Text] [Related]
15. Calcium channel blockers: an evidence-based review.
Waters D
Can J Cardiol; 1997 Aug; 13(8):757-66. PubMed ID: 9284842
[TBL] [Abstract][Full Text] [Related]
16. Amlodipine better than lisinopril? How one randomized clinical trial ended fallacies from observational studies.
Messerli FH; Staessen JA
Hypertension; 2006 Sep; 48(3):359-61. PubMed ID: 16894055
[No Abstract] [Full Text] [Related]
17. Calcium-channel antagonists in cardiovascular disease.
Holdright DR
Br J Hosp Med; 1997 Jun 4-17; 57(11):552-6. PubMed ID: 9307671
[TBL] [Abstract][Full Text] [Related]
18. Individual responses to converting enzyme inhibitors and calcium antagonists.
Bidiville J; Nussberger J; Waeber G; Porchet M; Waeber B; Brunner HR
Hypertension; 1988 Feb; 11(2):166-73. PubMed ID: 2830189
[TBL] [Abstract][Full Text] [Related]
19. Impact of plaque burden on compensatory enlargement of coronary arteries in cardiac allograft vasculopathy. Working Group on Cardiac Allograft Vasculopathy.
Pethig K; Heublein B; Wahlers T
Am J Cardiol; 1997 Jan; 79(1):89-92. PubMed ID: 9024747
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.
O'Donnell MJ; Rowe BR; Lawson N; Horton A; Gyde OH; Barnett AH
J Hum Hypertens; 1993 Aug; 7(4):333-9. PubMed ID: 8410924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
